Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 84.85 USD 0.84% Market Closed
Market Cap: 4.2B USD
Have any thoughts about
Prestige Consumer Healthcare Inc?
Write Note

Intrinsic Value

The intrinsic value of one PBH stock under the Base Case scenario is 77.13 USD. Compared to the current market price of 84.85 USD, Prestige Consumer Healthcare Inc is Overvalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PBH Intrinsic Value
77.13 USD
Overvaluation 9%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Prestige Consumer Healthcare Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PBH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PBH?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Prestige Consumer Healthcare Inc

Provide an overview of the primary business activities
of Prestige Consumer Healthcare Inc.

What unique competitive advantages
does Prestige Consumer Healthcare Inc hold over its rivals?

What risks and challenges
does Prestige Consumer Healthcare Inc face in the near future?

Has there been any significant insider trading activity
in Prestige Consumer Healthcare Inc recently?

Summarize the latest earnings call
of Prestige Consumer Healthcare Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Prestige Consumer Healthcare Inc.

Provide P/S
for Prestige Consumer Healthcare Inc.

Provide P/E
for Prestige Consumer Healthcare Inc.

Provide P/OCF
for Prestige Consumer Healthcare Inc.

Provide P/FCFE
for Prestige Consumer Healthcare Inc.

Provide P/B
for Prestige Consumer Healthcare Inc.

Provide EV/S
for Prestige Consumer Healthcare Inc.

Provide EV/GP
for Prestige Consumer Healthcare Inc.

Provide EV/EBITDA
for Prestige Consumer Healthcare Inc.

Provide EV/EBIT
for Prestige Consumer Healthcare Inc.

Provide EV/OCF
for Prestige Consumer Healthcare Inc.

Provide EV/FCFF
for Prestige Consumer Healthcare Inc.

Provide EV/IC
for Prestige Consumer Healthcare Inc.

Show me price targets
for Prestige Consumer Healthcare Inc made by professional analysts.

What are the Revenue projections
for Prestige Consumer Healthcare Inc?

How accurate were the past Revenue estimates
for Prestige Consumer Healthcare Inc?

What are the Net Income projections
for Prestige Consumer Healthcare Inc?

How accurate were the past Net Income estimates
for Prestige Consumer Healthcare Inc?

What are the EPS projections
for Prestige Consumer Healthcare Inc?

How accurate were the past EPS estimates
for Prestige Consumer Healthcare Inc?

What are the EBIT projections
for Prestige Consumer Healthcare Inc?

How accurate were the past EBIT estimates
for Prestige Consumer Healthcare Inc?

Compare the revenue forecasts
for Prestige Consumer Healthcare Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Prestige Consumer Healthcare Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Prestige Consumer Healthcare Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Prestige Consumer Healthcare Inc compared to its peers.

Compare the P/E ratios
of Prestige Consumer Healthcare Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Prestige Consumer Healthcare Inc with its peers.

Analyze the financial leverage
of Prestige Consumer Healthcare Inc compared to its main competitors.

Show all profitability ratios
for Prestige Consumer Healthcare Inc.

Provide ROE
for Prestige Consumer Healthcare Inc.

Provide ROA
for Prestige Consumer Healthcare Inc.

Provide ROIC
for Prestige Consumer Healthcare Inc.

Provide ROCE
for Prestige Consumer Healthcare Inc.

Provide Gross Margin
for Prestige Consumer Healthcare Inc.

Provide Operating Margin
for Prestige Consumer Healthcare Inc.

Provide Net Margin
for Prestige Consumer Healthcare Inc.

Provide FCF Margin
for Prestige Consumer Healthcare Inc.

Show all solvency ratios
for Prestige Consumer Healthcare Inc.

Provide D/E Ratio
for Prestige Consumer Healthcare Inc.

Provide D/A Ratio
for Prestige Consumer Healthcare Inc.

Provide Interest Coverage Ratio
for Prestige Consumer Healthcare Inc.

Provide Altman Z-Score Ratio
for Prestige Consumer Healthcare Inc.

Provide Quick Ratio
for Prestige Consumer Healthcare Inc.

Provide Current Ratio
for Prestige Consumer Healthcare Inc.

Provide Cash Ratio
for Prestige Consumer Healthcare Inc.

What is the historical Revenue growth
over the last 5 years for Prestige Consumer Healthcare Inc?

What is the historical Net Income growth
over the last 5 years for Prestige Consumer Healthcare Inc?

What is the current Free Cash Flow
of Prestige Consumer Healthcare Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Prestige Consumer Healthcare Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Prestige Consumer Healthcare Inc

Current Assets 380.7m
Cash & Short-Term Investments 51.5m
Receivables 163.5m
Other Current Assets 165.6m
Non-Current Assets 2.9B
PP&E 83.7m
Intangibles 2.8B
Other Non-Current Assets 6.7m
Current Liabilities 106.9m
Accounts Payable 31.2m
Accrued Liabilities 75.5m
Other Current Liabilities 195k
Non-Current Liabilities 1.5B
Long-Term Debt 1.1B
Other Non-Current Liabilities 426.5m
Efficiency

Earnings Waterfall
Prestige Consumer Healthcare Inc

Revenue
1.1B USD
Cost of Revenue
-497.5m USD
Gross Profit
613.2m USD
Operating Expenses
-287.8m USD
Operating Income
325.4m USD
Other Expenses
-119.4m USD
Net Income
205.9m USD

Free Cash Flow Analysis
Prestige Consumer Healthcare Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2, Prestige Consumer Healthcare reported sales of $284 million, slightly down from last year, largely due to supply constraints for Clear Eyes. However, growth in their International segment and brands like Hydralyte helped offset this decline. They anticipate full-year revenues of $1.125 billion to $1.140 billion, with adjusted EPS expected between $4.40 and $4.46. The company is confident in achieving approximately 1% organic growth, aided by improvements in the Clear Eyes supply chain and strategic marketing initiatives. With a robust free cash flow forecast of over $240 million, they plan to continue share buybacks and focus on prudent capital deployment.

What is Earnings Call?
Fundamental Scores

PBH Profitability Score
Profitability Due Diligence

Prestige Consumer Healthcare Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Years Revenue Growth
57/100
Profitability
Score

Prestige Consumer Healthcare Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

PBH Solvency Score
Solvency Due Diligence

Prestige Consumer Healthcare Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Average Altman Z-Score
50/100
Solvency
Score

Prestige Consumer Healthcare Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PBH Price Targets Summary
Prestige Consumer Healthcare Inc

Wall Street analysts forecast PBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBH is 89.59 USD with a low forecast of 81.81 USD and a high forecast of 99.75 USD.

Lowest
Price Target
81.81 USD
4% Downside
Average
Price Target
89.59 USD
6% Upside
Highest
Price Target
99.75 USD
18% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PBH?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PBH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PBH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

4.2B USD

Dividend Yield

0%

Description

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 505 full-time employees. The company went IPO on 2005-02-10. The firm operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet TopCo, LLC, C.B. Fleet HoldCo, LLC, C.B. Fleet, LLC, C.B. Fleet Company, Incorporated and C.B. Fleet Investment Corporation.

Contact

NEW YORK
Tarrytown
660 White Plains Rd
+19145246800.0
prestigebrands.com

IPO

2005-02-10

Employees

505

Officers

Chairman, President & CEO
Mr. Ronald M. Lombardi
Chief Financial Officer
Ms. Christine Sacco
Senior Vice President of Operations
Mr. Jeffrey Zerillo
Senior VP, General Counsel & Corporate Secretary
Mr. William C. P'Pool
Executive Vice President of Marketing & Sales
Mr. Adel Mekhail
Director of Investor Relations
Mr. Philip David Terpolilli
Show More
Director of Communications
Dean Siegal
Senior Vice President of Quality & Regulatory Affairs
Ms. Mary Beth Fritz
Show Less

See Also

Discover More
What is the Intrinsic Value of one PBH stock?

The intrinsic value of one PBH stock under the Base Case scenario is 77.13 USD.

Is PBH stock undervalued or overvalued?

Compared to the current market price of 84.85 USD, Prestige Consumer Healthcare Inc is Overvalued by 9%.

Back to Top